Diogo Pinto,  —

Articles by Diogo Pinto

FDA Gives Galafold Accelerated Approval for Treatment of Fabry Patients

The U.S. Food and Drug Administration has granted accelerated approval to Galafold (migalastat) 123 mg capsules to treat adults with a confirmed diagnosis of Fabry disease who have an amenable galactosidase alpha gene (GLA) mutation. “This FDA approval of Galafold is a transformative moment for people in the U.S. living…